Found: 96
Select item for more details and to access through your institution.
Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 10, p. 4033, doi. 10.1007/s00277-024-05923-5
- By:
- Publication type:
- Article
Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 615, doi. 10.1002/ajh.27246
- By:
- Publication type:
- Article
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 3, p. 360, doi. 10.1002/ajh.27187
- By:
- Publication type:
- Article
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E32, doi. 10.1002/ajh.27161
- By:
- Publication type:
- Article
Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3‐ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 274, doi. 10.1002/ajh.26442
- By:
- Publication type:
- Article
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. 40, doi. 10.1002/ajh.26000
- By:
- Publication type:
- Article
Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1135, doi. 10.1002/ajh.25905
- By:
- Publication type:
- Article
The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA‐matched allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 282, doi. 10.1002/ajh.25714
- By:
- Publication type:
- Article
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 2, p. 231, doi. 10.1002/ajh.25355
- By:
- Publication type:
- Article
Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1236, doi. 10.1002/ajh.25231
- By:
- Publication type:
- Article
T‐cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3‐ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. 736, doi. 10.1002/ajh.25082
- By:
- Publication type:
- Article
Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 31, doi. 10.1002/ajh.24928
- By:
- Publication type:
- Article
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 789, doi. 10.1002/ajh.24771
- By:
- Publication type:
- Article
Chemotherapy Dose Adjustment for Obese Patients Undergoing Hematopoietic Stem Cell Transplantation: A Survey on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
- Published in:
- Oncologist, 2015, v. 20, n. 1, p. 50, doi. 10.1634/theoncologist.2014-0187
- By:
- Publication type:
- Article
Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1260470
- By:
- Publication type:
- Article
Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain.
- Published in:
- ClinicoEconomics & Outcomes Research, 2019, v. 11, p. 683, doi. 10.2147/CEOR.S222879
- By:
- Publication type:
- Article
Infrequent Presentations of Chronic NPM1 -Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 705, doi. 10.3390/cancers16040705
- By:
- Publication type:
- Article
A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1912, doi. 10.3390/cancers15061912
- By:
- Publication type:
- Article
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4107, doi. 10.3390/cancers14174107
- By:
- Publication type:
- Article
PLZF-RARα, NPM1-RARα, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1313, doi. 10.3390/cancers12051313
- By:
- Publication type:
- Article
Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01060-4
- By:
- Publication type:
- Article
Refining the Diagnosis and Prognostic Categorization of Acute Myeloid Leukemia Patients with an Integrated Use of Cytogenetic and Molecular Studies.
- Published in:
- Acta Haematologica, 2013, v. 129, n. 2, p. 65, doi. 10.1159/000343616
- By:
- Publication type:
- Article
Histamine receptor 1 is expressed in leukaemic cells and affects differentiation sensitivity.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 22, p. 13536, doi. 10.1111/jcmm.15930
- By:
- Publication type:
- Article
Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: A survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 17, p. 2760, doi. 10.1002/cncr.28768
- By:
- Publication type:
- Article
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: Final results of a phase 2 study (Burkimab)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 9, p. 1660, doi. 10.1002/cncr.27918
- By:
- Publication type:
- Article
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 2, p. 410, doi. 10.1002/cncr.26273
- By:
- Publication type:
- Article
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia.
- Published in:
- Cancer Cell International, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12935-023-02944-4
- By:
- Publication type:
- Article
Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 6, p. 1454, doi. 10.1093/jac/dkad105
- By:
- Publication type:
- Article
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
- By:
- Publication type:
- Article
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
- By:
- Publication type:
- Article
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32306-4
- By:
- Publication type:
- Article
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 138, doi. 10.1111/ejh.13417
- By:
- Publication type:
- Article
Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 3, p. 162, doi. 10.1111/ejh.13346
- By:
- Publication type:
- Article
Increased survival due to lower toxicity for high‐risk T‐cell acute lymphoblastic leukemia patients in two consecutive pediatric‐inspired PETHEMA trials.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 1, p. 79, doi. 10.1111/ejh.13178
- By:
- Publication type:
- Article
Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 3, p. 209, doi. 10.1111/ejh.12130
- By:
- Publication type:
- Article
Spontaneous rupture of the spleen as immediate complication in autologous transplantation for primary systemic amyloidosis.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 2, p. 182, doi. 10.1111/j.1600-0609.2007.01005.x
- By:
- Publication type:
- Article
Long-term results of thalidomide in refractory and relapsed multiple myeloma with emphasis on response duration.
- Published in:
- European Journal of Haematology, 2006, v. 77, n. 6, p. 486, doi. 10.1111/j.0902-4441.2006.t01-1-EJH2783.x
- By:
- Publication type:
- Article
High-Dose Chemotherapy and Immunotherapy in Adult Burkitt Lymphoma: Comparison of Results in Human Immunodeficiency Vfrus-lnfected and Noninfected Patients.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 1, p. 117, doi. 10.1002/cncr.23522
- By:
- Publication type:
- Article
Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens.
- Published in:
- Cancer (0008543X), 2001, v. 91, n. 8, p. 1557, doi. 10.1002/1097-0142(20010415)91:8<1557::AID-CNCR1165>3.0.CO;2-4
- By:
- Publication type:
- Article
Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced hodgkin disease.
- Published in:
- Cancer (0008543X), 2000, v. 88, n. 9, p. 2142, doi. 10.1002/(SICI)1097-0142(20000501)88:9<2142::AID-CNCR21>3.0.CO;2-M
- By:
- Publication type:
- Article
Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 9, p. 2556, doi. 10.1093/jac/dku150
- By:
- Publication type:
- Article
Clinical Characteristics and Outcome of Bloodstream Infections in HIV-Infected Patients with Cancer and Febrile Neutropenia: A Case–Control Study.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 2, p. 955, doi. 10.1007/s40121-021-00445-3
- By:
- Publication type:
- Article
Machine Learning to Assess the Risk of Multidrug-Resistant Gram-Negative Bacilli Infections in Febrile Neutropenic Hematological Patients.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 2, p. 971, doi. 10.1007/s40121-021-00438-2
- By:
- Publication type:
- Article
Novel Tools for Diagnosis and Monitoring of AML.
- Published in:
- Current Oncology, 2023, v. 30, n. 6, p. 5201, doi. 10.3390/curroncol30060395
- By:
- Publication type:
- Article